Clotting Factor (CF) Product Administration And Risk Of Thrombotic Adverse Events (TES) Among The Inpatient U.S. Elderly Medicare Beneficiaries, During 2009-2015 Study Period

May 1, 2018, 00:00
10.1016/j.jval.2018.04.328
https://www.valueinhealthjournal.com/article/S1098-3015(18)30628-4/fulltext
Title : Clotting Factor (CF) Product Administration And Risk Of Thrombotic Adverse Events (TES) Among The Inpatient U.S. Elderly Medicare Beneficiaries, During 2009-2015 Study Period
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30628-4&doi=10.1016/j.jval.2018.04.328
First page :
Section Title :
Open access? : No
Section Order : 1191
Categories :
Tags :
Regions :
ViH Article Tags :